In this study, a prospective, randomized, double-blind pilot trial designed to evaluate the
effect of histamine H1 receptor antagonist clemastine on perioperative anaphylaxis in
cardiovascular surgery with cardiopulmonary bypass, especially for the efficacy and safety on
reducing heparin and protamine associated anaphylaxis.
Phase:
N/A
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital